Since high-affinity adenosine A2 receptors (A2u) are localized exclusively in dopamine-rich regions in the central nervous system and mediate inhibition of locomotor activity, we have examined the effect of A2 receptor activation on D1 and D2 receptor binding in membrane preparations of the rat striatum. The A2a agonist 2-p-(2-carboxyethyl)phen- ethylaminoJ-5'-N-ethylcarboxamidoadenosine (CGS 21680) Adenosine has been shown to function as a neuromodulator in many areas of the mammalian central nervous system (1-3). These actions of adenosine are mediated by receptors that can be subdivided into Al and A2 subtypes based on relative agonist and antagonist potencies (4, 5). Al activation inhibits and A2 activation stimulates adenylate cyclase (4, 6, 7). The A2 receptors have been further subclassified into high-affinity (A2a) and low-affinity (A2b) receptors, based on agonist potencies with regard to adenylate cyclase activation (4) and receptor binding (5). The A2b receptors are widely distributed in the brain and mediate the stimulatory action of high concentrations of adenosine agonists on cAMP formation, which could affect dopamine release and synthesis (8, 9) . In contrast, A2a receptors are exclusively localized to dopamine-innervated areas ofthe central nervous system (10, 11), with a postsynaptic distribution (12) similar to that of postsynaptic D1 and D2 receptors (13). By using in situ hybridization the recently cloned A2a receptors (14) have been found to be localized to striatal medium-sized neurons (15).
[3Hlraclopride and failed to affect ligand binding to D1 receptors. Thus, stimulation of A21 receptors potently reduces the affinity of D2 agonist binding sites within the plasma membrane of striatal neurons. This A2,-D2 interaction may underlie the neuroleptic-like actions of adenosine agonists and the enhancing effects of adenosine antagonists, such as caffeine, on locomotor activity.
Adenosine has been shown to function as a neuromodulator in many areas of the mammalian central nervous system (1) (2) (3) . These actions of adenosine are mediated by receptors that can be subdivided into Al and A2 subtypes based on relative agonist and antagonist potencies (4, 5) . Al activation inhibits and A2 activation stimulates adenylate cyclase (4, 6, 7) . The A2 receptors have been further subclassified into high-affinity (A2a) and low-affinity (A2b) receptors, based on agonist potencies with regard to adenylate cyclase activation (4) and receptor binding (5) . The A2b receptors are widely distributed in the brain and mediate the stimulatory action of high concentrations of adenosine agonists on cAMP formation, which could affect dopamine release and synthesis (8, 9) . In contrast, A2a receptors are exclusively localized to dopamine-innervated areas ofthe central nervous system (10, 11) , with a postsynaptic distribution (12) similar to that of postsynaptic D1 and D2 receptors (13) . By using in situ hybridization the recently cloned A2a receptors (14) have been found to be localized to striatal medium-sized neurons (15) .
Adenosine agonists inhibit, whereas adenosine antagonists, including caffeine, enhance spontaneous (16, 17) and dopamine-induced locomotor activity (16, (18) (19) (20) . The potencies of adenosine agonists in producing hypomotility correlate with their affinities for Au adenosine receptors (21, 22) , suggesting that A2. receptors mediate most of the behavioral effects of adenosine agonists. The hypomotility induced by adenosine agonists resembles that induced by classical neuroleptics (22) , which act by blocking postsynaptic D2 receptors (23) . In fact, behavioral evidence for a negative interaction between postsynaptic A2. and D2 receptors has recently been obtained using acutely reserpinized mice (24, 25) . Since activation of postsynaptic D2 receptors seems to be a necessary step for locomotor behavior, a negative interaction between postsynaptic A2. and D2 receptors could explain the hypomotility induced by adenosine agonists and the enhancement of locomotor activity induced by adenosine antagonists, including caffeine (24, 25) .
In contrast to the A2a receptor, the D2 receptor mediates an inhibition of adenylate cyclase (26) . However, the stimulatory activity of A2a receptors on adenylate cyclase cannot simply explain the counteractive action of A2a stimulation on D2-mediated locomotor activity since D, receptors, which also stimulate adenylate cyclase, potentiate D2-mediated locomotor activity (24) . One possibility could be the existence of a more direct interaction between A2a and D2 receptors. Earlier studies have shown that L-glutamate (27) , SCH 23390 (28) , and neuropeptides such as neurotensin (29) (30) (31) 44 ) and cholecystokinins 4 and -8 (32) tTo whom reprint requests should be addressed. (Table 2) . DISCUSSION The present study has shown that stimulation of adenosine A2a receptors causes a reduction in the affinity of dopamine (39) , the dissociation constants of high-affinity and low-affinity D2 agonist binding (KH and KL) were estimated to 3.9 nM and 148 nM under control conditions and 11.8 nM and 363 nM in the presence of CGS 21680. (41, 42) . These results suggest that the effect of A2a receptors, which are coupled to G proteins (11) , is mediated by a different mechanism than the effect of GTP. This mechanism may be similar to the G protein-independent mechanism mediating the neurotensin-D2 interaction (31, 44) , whereas the D1-D2 interaction seems to involve G proteins (28) . (31, 44) and may be due to a desensitization of the A2 teceptor that is taking place within the plasma membrane or the exhaustion of some essential endogenous factor. However, it differs from the monophasic decrease in D2 agonist binding seen following treatment with neurotensin in vivo (43) or with direct D2 antagonists.
In conclusion, the present study has revealed that stimulation of A-receptors potently reduces the affinity of D2 agonist binding sites in striatal membranes. This interaction, which is the strongest receptor-receptor interaction at the binding site hitherto observed, could explain the neurolepticlike effects of adenosine agonists and why adenosine antagonists, such as caffeine, enhance locomotor activity.
